BRII-B
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-20
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
Rowena is recorded as Analyst at Leerink Partners. Rowena has spoken on 1 earnings call across 1 company, most recently for BRII-B on March 20, 2026. The companies whose calls Rowena spoke on are classified in the Healthcare sector.
“First on the HBV studies, I know a couple of them completed enrollment. And I was curious, could you help frame your expectations for the data for the Enriched and Enhanced studies?”
Leerink Partners
Analyst
Transcript header (unverified)
BRII-B
Biotechnology · Healthcare
Brii Biosciences 2025 Annual Results Conference Call
BRII-B